The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment

• Váldodahkkit: Yuanyuan Liu (Dahkki), Shanwu Yu (Dahkki), Yixiang Chen (Dahkki), Zhihong Hu (Dahkki), Lingling Fan (Dahkki), Gaofeng Liang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Hematologic malignancies (HMs), also referred to as hematological or blood cancers, pose significant threats to patients as they impact the blood, bone marrow, and lymphatic system. Despite significant clinical strategies using chemotherapy, radiotherapy, stem cell transplantation, targeted molecula...